Concordia Healthcare Corp (CXRX-Q) Stock Predictions - Stockchase
WATCH LIST
2
Concordia Healthcare Corp (CXRX-Q)

ON STOCKCHASE SINCE May 2016

Healthcare

Concordia Healthcare Corp

CXRX-Q

2 watching          
Join the Discussion

Concordia Healthcare Corp (CXRX-Q) SAVE Mar, 25, 2019, 2:42 pm

0.19 0 (0%)

About Concordia Healthcare Corp (CXRX-Q)

Concordia Healthcare Corp is a publicly traded pharmaceutical company based in Canada. The company focuses on Attention-Deficit Hyperactivity Disorder, cancer and asthma. More at Wikipedia

What the experts are saying about CXRX-Q



  • All
  • Filtered
Signal Opinion Expert
PAST TOP PICK

(A Top Pick May 3/16. Down 95%.) This was a mistake. There are shareholder lawsuits involved. It was growth by acquisition, and it looks like they dramatically overpaid for some assets. They got involved with generic competition, and as well, the perfect storm of politics of the last election really killed the stock.

Healthcare
0 0 0 0 0
0 comments

(A Top Pick May 3/16. Down 95%.) This was a mistake. There are shareholder lawsuits involved. It was growth by acquisition, and it looks like they dramatically overpaid for some assets. They got involved with generic competition, and as well, the perfect storm of politics of the last election really killed the stock.

Healthcare
0 0 0 0 0
0 comments
John O'Connell,

Chairman a, Davis Rea...

Price Price
$1.390
Owned Owned
No

TOP PICK

This has grown by acquisition, buying a lot of drugs. They sell drugs to over 100 companies. Generates EBITDA of around $600 million. Have $3.5 billion of debt. They free cash flow $300 million a year which they can pay down the debt with. Thinks there is a very good chance this company will not be public in a couple of weeks. Dividend yield of 1.14%.

Healthcare
0 0 0 0 0
0 comments

This has grown by acquisition, buying a lot of drugs. They sell drugs to over 100 companies. Generates EBITDA of around $600 million. Have $3.5 billion of debt. They free cash flow $300 million a year which they can pay down the debt with. Thinks there is a very good chance this company will not be public in a couple of weeks. Dividend yield of 1.14%.

Healthcare
0 0 0 0 0
0 comments
John O'Connell,

Chairman a, Davis Rea...

Price Price
$26.420
Owned Owned
Yes

Showing 1 to 2 of 2 entries
Successfully Saved Company
Successfully Saved Company
0+
JOIN THE DISCUSSION
0 comments in the last 7 days